Polomar Health Services, Inc. 8-K

What Happened
Polomar Health Services, Inc. (PMHS) announced that on April 23, 2026 it received a written notice from ForHumanity, Inc. stating ForHumanity intends to terminate and rescind the Product Fulfillment and Distribution Agreement (the “ForHumanity Agreement”), originally executed March 12, 2025 and amended multiple times through December 5, 2025. ForHumanity alleges certain Company representations were false and that it was induced to enter the agreement by reliance on those representations. Polomar says it believes those claims are without merit, that ForHumanity lacks standing to terminate, and that ForHumanity is in default under the agreement. The Company is evaluating the notice and related claims.

Key Details

• The ForHumanity Agreement granted ForHumanity exclusive marketing rights for certain Polomar pharmaceutical products and engaged Island Group 40, LLC (IG4) to provide account management services. Polomar remains responsible for fulfilling valid prescriptions.
• Contract term: initial 42‑month license term (auto‑renewable if ForHumanity meets revenue commitments).
• Guaranteed payment: $750,000 to Polomar; $500,000 has been paid to date.
• Exclusivity and revenue milestones: exclusivity through June 30, 2026 (extendable to Dec 31, 2026 if ForHumanity generates ≥ $1,750,000 gross revenue to Polomar in H1 2026); further extensions tied to higher revenue goals (e.g., extension through June 30, 2027 if ForHumanity delivers $5,000,000 gross revenue for 2026).

Why It Matters
A termination or dispute over this agreement could affect Polomar’s marketed distribution and near‑term revenue expectations tied to the ForHumanity relationship and its milestone payments. Polomar has acknowledged obligations to fulfill prescriptions regardless of the dispute, and the company’s statement that ForHumanity is in default signals a potential legal or commercial conflict that may create uncertainty, costs, or timing changes for revenue recognition. Investors should watch for further company updates, any litigation or settlement filings, and impacts on revenue tied to the ForHumanity milestones.